Votre sélection est vide.
Sélectionnez des ETF pour les comparer les uns aux autres.
Ajoutez un ETF à la sélection en le sélectionnant dans le sélecteur d’ETF ou sous « Comparer » sous le profil de l’ETF.
Trouver cet ETF chez un courtier
| Index | MSCI USA Health Care |
| Investment focus | Actions, États-Unis, Santé |
| Fund size | EUR 882 m |
| Total expense ratio | 0,12% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Non |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 15,93% |
| Inception/ Listing Date | 12 septembre 2017 |
| Distribution policy | Distributing |
| Distribution frequency | Semi annually |
| Fund domicile | Irlande |
| Fund Provider | Xtrackers |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 décembre |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% d’exonération partielle |
| Switzerland | ESTV Reporting |
| Austria | Meldefonds |
| UK | UK Reporting |
| Italy | 26,0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Eli Lilly & Co. | 15,07% |
| Johnson & Johnson | 10,32% |
| AbbVie, Inc. | 7,22% |
| Merck & Co., Inc. | 5,86% |
| UnitedHealth Group Inc | 5,70% |
| Amgen, Inc. | 3,73% |
| Thermo Fisher Scientific, Inc. | 3,70% |
| Abbott Laboratories | 3,13% |
| Gilead Sciences, Inc. | 2,89% |
| Pfizer Inc. | 2,54% |
| États-Unis | 97,76% |
| Irlande | 2,24% |
| Autre | 0,00% |
| Soins de santé | 98,11% |
| Biens de consommation non cycliques | 1,89% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0,00 € | 0,00 € | Voir l'offre* | |
| | 0,00 € | 0,00 € | Voir l'offre** | |
| | 0,00 € | 0,00 € | Voir l'offre* | |
| | 0,00 € | 0,00 € | Voir l'offre* |
| YTD | +20.65% |
| 1 month | +8.47% |
| 3 months | +13.85% |
| 6 months | +26.94% |
| 1 year | +27.79% |
| 3 years | +35.88% |
| 5 years | +47.69% |
| Since inception (MAX) | +157.41% |
| 2025 | +1.00% |
| 2024 | +8.83% |
| 2023 | -1.66% |
| 2022 | +2.98% |
| Rendement actuel de distribution | 1,08% |
| Dividends (last 12 months) | EUR 0,69 |
| Period | Dividend in EUR | Dividend yield in % |
|---|---|---|
| 1 an | EUR 0,69 | 1,37% |
| 2025 | EUR 0,69 | 1,29% |
| 2024 | EUR 0,65 | 1,30% |
| 2023 | EUR 0,61 | 1,19% |
| 2022 | EUR 0,84 | 1,65% |
| Volatility 1 year | 15.93% |
| Volatility 3 years | 15.49% |
| Volatility 5 years | 16.55% |
| Return per risk 1 year | 1.74 |
| Return per risk 3 years | 0.69 |
| Return per risk 5 years | 0.49 |
| Maximum drawdown 1 year | -11.62% |
| Maximum drawdown 3 years | -21.84% |
| Maximum drawdown 5 years | -21.84% |
| Maximum drawdown since inception | -27.86% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XUHC | - - | - - | - |
| Bourse de Stuttgart | EUR | XUHC | - - | - - | - |
| London Stock Exchange | GBX | XSHC | XSHC LN XUHCEUIV | XSHC.L XUHCEURINAV=SOLA | |
| London Stock Exchange | USD | XUHC | XUHC LN XUHCUSIV | XUHC.L XUHCUSDINAV=SOLA | |
| SIX Swiss Exchange | CHF | XUHC | XUHC SW XSHCGBIV | XUHC.S XSHCINAV=SOLA | |
| SIX Swiss Exchange | USD | XUHC | XSHCGBIV | XSHCINAV=SOLA | |
| XETRA | EUR | XUHC | XUHC GY | XUHC.DE |
| Nom du fonds | Taille du fonds en M € (AuM) | Frais annuels | Distribution | Réplication |
|---|---|---|---|---|
| iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2 959 | 0,15% p.a. | Capitalisation | Complète |
| iShares Nasdaq US Biotechnology UCITS ETF | 1 038 | 0,35% p.a. | Capitalisation | Échantillonnage |
| State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF USD | 556 | 0,15% p.a. | Capitalisation | Complète |
| Invesco US Health Care Sector UCITS ETF | 510 | 0,14% p.a. | Capitalisation | Synthétique |
| Invesco Nasdaq Biotech UCITS ETF | 498 | 0,40% p.a. | Capitalisation | Synthétique |